Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Charles River Laboratories has acquired Blue Stream Laboratories, Inc. Combining Blue Stream with Charles River’s existing discovery, safety assessment, and biologics capabilities creates a leading provider with the ability to support biologic and ...
read more
Wednesday, April 06, 2022
Charles River Laboratories International, Inc. has acquired Explora BioLabs Holdings, Inc., a provider of contract vivarium research services.
read more
Thursday, January 27, 2022
Charles River Laboratories International, Inc. has announced the expansion of their strategic partnership with Chicago, Illinois-based SAMDI Tech, Inc. Under the existing partnership, established in 2018, SAMDI Tech clients have access to Charles ...
read more
Charles River Laboratories announced the expansion of its service capabilities in early discovery screening.
read more
Thursday, January 12, 2023
Charles River Laboratories International, Inc. announced the launch of its eXpDNA™ plasmid platform, established from the Company’s contract development and manufacturing (CDMO) and biologics testing experience.
read more
Wednesday, January 21, 2026
Charles River Laboratories International and Gazi University Faculty of Medicine, announced a gene therapy contract development and manufacturing organization (CDMO) collaboration, providing plasmid DNA for AAV production and in vitro efficacy ...
read more
Charles River has completed the previously announced acquisition of Cognate BioServices for approximately $875 million.
read more
Wednesday, October 17, 2018
Charles River announced it was awarded a five-year, $95.7 million contract by the National Institute of Allergy and Infectious Diseases, one of the largest institutes of the NIH.
read more
Tuesday, September 08, 2026
Charles River Laboratories has brought a fully automated production suite for Endosafe bacterial endotoxin testing cartridges into full operation, increasing manufacturing capacity and adding inspection and digital-traceability functions.
read more
Wednesday, September 21, 2022
Charles River Associates announced that Kenneth J. Beers has joined CRA as a Vice President in the Company’s Life Sciences Practice.
read more
Monday, December 12, 2016
Charles River Associates, a worldwide provider of economic, financial, and management consulting services, announced that Justus Dehnen has joined the firm as a vice president in the Life Sciences Practice based in Munich. Mr. Dehnen specializes in ...
read more
Charles River Laboratories reported its results for the second quarter of 2017.
read more
Wednesday, April 10, 2024
Charles River Laboratories International, Inc. announced a plasmid DNA contract development and manufacturing organization (CDMO) collaboration with Axovia Therapeutics Ltd. Charles River will manufacture High Quality (HQ) gene of interest plasmid to...
read more
Thursday, January 28, 2021
Charles River Laboratories has entered into a strategic partnership with Cypre, a biotechnology company that is using 3D hydrogel technology.
read more
Wednesday, December 18, 2019
Charles River Laboratories has entered into an exclusive Discovery and Safety Services partnership with Bit Bio.
read more